Methods: Consecutive patients who underwent IVUS analysis after drug-eluting stent implantation for de novo lesions were evaluated. Stent length was studied using automatic pullback of an IVUS catheter (Boston Scientific Corp/SCIMED, MN) and was further analyzed for change in length (IVUS -label)(mm), the absolute change in length [|IVUS -label|](mm), and the absolute value of the relative change in length [|(IVUS-label)|/ label](%). Results: A total of 183 stents were included: 38.3% sirolimus-eluting stents (SES); 27.9% zotarolimus-eluting stents (ZES); 20.2% Co-Ch everolimus-eluting stents (Cc-EES); 7.1% Pl-Ch everolimus-eluting stents (Pc-EES) -the Element platform and 6.6% paclitaxel-eluting stents (PES). The change in stent length (mm) and the relative change in length (%) differed between groups: SES 0.3 Ϯ 1.2; ZES 1.0 Ϯ 1.3; Cc-EES 0.6 Ϯ 1.0; Pc-EES 0.4 Ϯ 1.1; PES Ϫ0.1 Ϯ 1.4 (pϭ0.008) and SES 1.7 Ϯ 6.0; ZES 5.7 Ϯ 6.7; Cc-EES 3.5 Ϯ 5.8; Pc-EES 2.3 Ϯ 6.0; PES Ϫ2.2 Ϯ 8.1 (p Ͻ0.001), respectively. Relative change in stent length was higher in the ZES group in comparison with SES and PES groups, (p Ͻ0.001 for both). There were no statistical differences between the Pc-EES (Element) and any other stent types. The rate of absolute relative change Ͼ5% in stent length was lower in the SES group compared to the other groups: SES 34%; ZES 63%; Cc-EES 54%; Pc-EES 46%; and PES 67% (pϭ0.02). Significant (Ͼ15%) absolute relative change in length was rare (3.8%) and did not differ between groups (pϭ0.54). Long stents (Ն20 mm, nϭ62) had a higher absolute change in length when compared to other stent groups (18 mm, nϭ50 and Յ16 mm, nϭ71): 1.3 Ϯ 1.0 vs. 1.0 Ϯ 0.6 vs. 1.0 Ϯ 0.6, respectively (pϭ0.02). Conclusions: IVUS analysis revealed that significant change in stent length after implantation was rare in all stent types. Stent axial integrity was influenced by stent length; longer stents displayed a higher absolute change in length than did shorter stents.
